A comparison of pertussis rates in the Northwest Territories: Pre- and postacellular pertussis vaccine introduction in children and adolescents

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 16, Issue 5, 2005, Pages 271-274

  Kandola, Kami ^a   Lea, Amy ^b   White, Wanda ^c   Santos, Maria ^c  

^a Stanton Territorial Health Authority   (Canada)

^b Yellowknife Health and Social Services   (Canada)

^c Department of Health and Social Services ^*  (Canada)

Author keywords

Acellular pertussis; Adolescent; Targeted; Vaccine

Indexed keywords

ACELLULAR VACCINE; DIPHTHERIA VACCINE; PERTUSSIS VACCINE; TETANUS TOXOID;

ADOLESCENT; ARTICLE; BORDETELLA PERTUSSIS; DRUG FORMULATION; HUMAN; IMMUNIZATION; INCIDENCE; MAJOR CLINICAL STUDY; PERTUSSIS;

EID: 28344455787     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2005/642315     Document Type: Article

References (13)

1. Canadian Paediatric Society. Acellular pertussis vaccine for adolescents. Paediatr Child Health 2003;8:378.
2. Robertson PW, Goldberg H, Jarvie BH, Smith DD, Whybin LR. Bordetella pertussis infection: A cause of persistent cough in adults. Med J Aust 1987;146:522-5.
3. Cromer BA, Goydos J, Hackell J, Mezzatesta J, Dekker C, Mortimer EA. Unrecognized pertussis infection in adolescents. Am J Dis Child 1993;147:575-7.
4. Aoyama T, Takeuchi Y, Goto A, Iwai H, Murase Y, Iwata T. Pertussis in adults. Am J Dis Child 1992;146:163-6.
5. Schmitt-Grohe S, Cherry JD, Heininger U, Uberall MA, Pineda E, Stehr K. Pertussis in German adults. Clin Infect Dis 1995;21:860-6.
6. Le T, Cherry JD, Chang SJ, et al. Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: The APERT Study. J Infect Dis 2004;190:535-44.
7. National Advisory Committee on Immunization. Canadian Immunization Guide, 6th edn. Ottawa: Canadian Medical Association, 2002:56.
8. National Advisory Committee on Immunization. Statement on adult/adolescent formulation of combined acellular pertussis, tetanus, and diphtheria vaccine. Canadian Communicable Disease Report, 2000.
9. Northwest Territories Bureau of Statistics. 2001 Census. 〈www.stats.gov.nt.ca/Statinfo/Census/census2001/Age-Sex.xls〉 (Version current at September 20, 2005).
10. Northwest Territories Bureau of Statistics. Births to females less than or equal to 19 years of age: Northwest Territories, 1991-2003. 〈http://www.stats.gov.nt.ca/statinfo/generalstats/scan/scan.html〉 (Version current at October 3, 2005).
11. von Konig CH, Halperin S, Riffelmann M, Guiso N. Pertussis of adults and infants. Lancet Infect Dis 2002;2:744-50.
12. Purdy KW, Hay JW, Botteman MF, Ward JI. Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: A cost-benefit analysis. Clin Infect Dis 2004;39:20-8.
13. Edmunds WJ, Brisson M, Melegaro A, Gay NJ. The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales. Vaccine 2002;20:1316-30.